key: cord-0786252-d464w62z authors: Liao, Liang; Yang, Guo‐hui title: Clinical significance of cellular immunity function and inflammatory factors assays in alveolar lavage fluid for severe COVID‐19 pneumonia date: 2021-02-09 journal: J Med Virol DOI: 10.1002/jmv.26827 sha: 23768322f16c213c0dd68078d0b0d548194cfe63 doc_id: 786252 cord_uid: d464w62z In this study, we aimed to investigate the changes of lymphocyte subsets (CD3(+), CD4(+), CD8(+)) and inflammatory factors (interleukin‐6 [IL‐6], hypersensitive C‐reactive protein [HS‐CRP], and procalcitonin [PCT]) of alveolar lavage fluid in patients with severe corona virus‐2019 (COVID‐19) pneumonia and their clinical impact on the assessment of disease severity and prognosis. Twenty‐four patients with severe COVID‐19 pneumonia were admitted to the intensive care unit (ICU) of the Ezhou Central Hospital from February 1 to March 22, 2020. According to the 28‐day prognosis, they were assigned to a death group and a survival group. On the 3rd day of ICU admission, peripheral blood and alveolar lavage fluid were collected for examination of lymphocyte subsets and inflammatory factors by flow cytometry and immunoturbidimetry, respectively. The CD3(+), CD4(+), and CD8(+) cell counts in alveolar lavage fluid and serum were significantly higher in the survival group than those of the death group (p < .05). The levels of IL‐6, HS‐CRP, and PCT in the alveolar lavage fluid and serum of the death group were statistically higher than those of the survival group (p < .05); The CD3(+), CD4(+) cell count, and IL‐6 level were negatively correlated with Sequential Organ Failure Assessment (SOFA) and Acute Physiology and Chronic Health Evaluation II scores, respectively (p < .05). The CD4(+) cell and SOFA score have a regression relationship for the prognosis of COVID‐19 severe patients. The CD3(+), CD4(+), CD8(+) cells, and IL‐6 levels are valuable in determining the prognosis of severe COVID‐19 pneumonia and are strongly correlated with the severity of the disease; the CD4(+) cell is an independent risk factor affecting the prognosis of COVID‐19 pneumonia. indicate that SARS-CoV-2 has angiotensin-converting enzyme 2 (ACE2) receptor binding domain, which can enter host cells through ACE2 6 and cause lung injury by invading cells with ACE2 as the receptor, and in addition to directly causing damage to lung tissue, the cytokine storm it triggers further aggravates the inflammatory response and can even develop into a systemic inflammatory response accompanied by shock, diffuse intravascular coagulation, and multiple organ failure (MOF). 2, 7, 8 Furthermore, a currently published retrospective study of cases shows that cytokine storm (cytokine release syndrome, CRS) is associated with high mortality of the disease 9 and the progressive increase of inflammatory factors such as C reactive protein (CRP) and interleukin-6 (IL-6) in peripheral blood can be used as early warning indicators, suggesting that CRP and IL-6 are of great significance to the severity of COVID-19 disease. 10 The level of T lymphocyte subsets has been found to provide certain guidance for the clinical treatment and prognosis of patients with viral pneumonia, 2 According to the 28-day prognosis, patients with severe COVID-19 pneumonia were assigned to a survival group and a death group. Ten patients were in the survival group, including seven males and three females, aged 40-76 years, with an average age of (61.30 ± 13.40) years. 14 patients were involved in the death group, including 10 males and 4 females, aged 45-80 years, with an average age of (65.80 ± 12.40) years. All patients were treated in accordance with the Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (7th edition) 5 : invasive MV, antiviral, anti-infection, fluid resuscitation, organ protection, maintenance of water-electrolyte acid-base balance, nutrition support, hormones, Chinese herbal medicine, and other supportive treatments. • Comparing the survival group and death group with alveolar lavage fluid and peripheral blood on CD3 + , CD4 + , CD8 + , IL-6, HS-CRP, and PCT. • Pearson correlation analysis of pulmonary alveolar lavage fluid and peripheral blood on CD3 + , CD4 + , CD8 + , IL-6, HS-CRP, and PCT with SOFA and APACHE II score, respectively. • Application of binary logistic regression was adopted to analyze the prognostic factors affecting severe COVID-19 patients. SPSS23.0 (SPSS Inc.) was used for statistical analysis. The measurement data are expressed as mean ± SD. The homogeneity of variance is analyzed by one-way ANOVA, LSD-t-Test, and t-test, uneven variance using the Kruskal-Wallis test. The adoption rate and composition ratio (%) of count data are described. Pearson correlation analysis and binary logistic regression analysis were used. Diagnostic efficacy was analyzed by plotting the receiver operating curve (ROC). p < .05 indicates a statistical difference. There was no statistically significant difference between the survival group and death group in gender and age (p > .05), and there was no significant difference in the primary disease between the survival group and death group (p > .05) ( Table 1 ). The SOFA and APACHE are two scoring systems that determine the prognosis of patients by measuring the degree of impairment of major organ function and are mainly used in ICU units. The higher the score, the higher the risk of death. In the study, the scores of SOFA and APACHE II were higher in the death group compared to the survival group (p < .05) ( Table 2 ). It is well known that lymphocyte subsets are closely associated with cellular immunity in humans. In terms of general trends, whether in serum or in alveolar lavage fluid, the lymphocyte subsets of the death T A B L E 1 Gender, age and primary disease in the survival group and death group (x̅ ± S) group are greatly decreased compared to the survival group. on the other hand, there was a significant increase in the related inflammatory factors in the death group ( Figure 1) . Specifically, the cell counts of CD3 + , CD4 + , and CD8 + in alveolar lavage fluid and serum in the survival group were significantly higher compared to the death group and were significantly lower in the alveolar lavage fluid of the death group than those in the serum (p <.05); the levels of IL-6, HS-CRP, and PCT of the alveolar lavage fluid and serum in the survival group were lower compared to the death group, in addition, these inflammatory factors were significantly higher in the alveolar lavage fluid of the death group than those in the serum group (p < .05) ( Table 3 ). 3.4 | Correlation analysis of immune and inflammatory factor indexes with SOFA score and APACHE II score in patients with severe COVID-19 pneumonia The levels of CD3 + , CD4 + cells, and IL-6 in alveolar lavage fluid of patients with severe COVID-19 pneumonia were negatively correlated with the SOFA score and APACHE II score, respectively (p < .05). In addition, the levels of CD8 + cells, PCT, and HS-CRP were not correlated with SOFA score and APACHE II score, respectively (p > .05) ( Table 4) . reduce the blood return to the heart and alter the hemodynamics of the heart, which in turn leads to a decrease in glomerular filtration rate and subsequent renal injury. 24 Secondly, due to the high expression of ACE2 in renal tubules, 25 SARS-CoV-2 may bind to ACE2 in the kidney and cause renal injury. A study found that SARS-CoV-2 has a higher affinity to ACE2 protein than SARS-CoV, 26 which might be the reason why SARS-CoV-2 is more likely to cause kidney injury. In addition, a few studies 27, 28 have indicated that some inflammatory factors can exacerbate kidney injuries, such as tumor necrosis factor and IL-6. Moreover, Li et al. 29 have reported that cytokine storm may be an important mechanism of viral sepsis and MODS in patients with COVID-19, including acute kidney injury. Furthermore, some autopsy findings have revealed that extensive endothelial cell damage in the heart, kidney, small intestine and liver in COVID- 19, 30 triggering excessive thrombin production, inhibiting fibrinolysis, and activating the complement pathway, causing a thrombotic inflammatory response, ultimately leading to microthrombus deposition and microvascular dysfunction, which may promote further evolution of acute tubular necrosis into cortical necrosis, resulting in irreversible renal failure. 16, 31 Obviously, SARS-CoV-2 can affect the cellular immunity of patients. T lymphocytes are involved in the cellular immune function of the body and can be divided into two subgroups, CD4 + and CD8 + T lymphocytes, which have killing and auxiliary killing functions, respectively. One clinical study has demonstrated that most patients with SARS-CoV-2 infection have decreased lymphocytes, 32 in addition, another study has shown that a significant decrease in the total number of lymphocytes indicates that coronavirus consumes many immune cells and suppresses the immune function of human cells, and the damage of T lymphocytes may be an important factor leading to the deterioration of the patient's condition. 33 There are differences in T lymphocyte subsets between critical and noncritical groups, but CD4 + T lymphocytes were more significantly decreased than CD8 + T lymphocytes in the critical group. 34 During the SARS outbreak in 2003, investigators also paid more attention to the T lymphocyte subsets. In the lung interstitium of SARS patients, CD8 + T cells account for approximately 80% of total infiltrating inflammatory cells and play an important role in clearing SARS-CoV from infected cells and inducing immune damage. 35 The depletion of CD4 + T cells is associated with recruitment of F I G U R E 2 ROC curve of prognostic factors in patients with severe COVID-19 pneumonia.COVID-19, coronavirus disease 2019; ROC, receiver operating curve; SOFA, Sequential Organ Failure Assessment lymphocytes in the lung, neutralizing antibodies and decreased cytokine production, resulting in strong immune response and interstitial pneumonia, which delays the clearance of SARS-CoV from the lung. 36 The combination of virus replication in the lower respiratory tract and abnormal immune response may have an impact on the severity of the disease, similar to what has been demonstrated in SARS and MERS. 33 Chiu, W et al. 37 have found that the level of T lymphocytes is strongly associated with the prognosis of patients with severe influenza-A virus infection and that patients with low CD4 + T cells have a higher risk of death within 28 days after admission. In inclusion of more than 100 SARS-CoV-2 infection cases with obesity, diabetes, and cardiocerebrovascular diseases also have continuously decreased in lymphocytes and increased ferritin and cytokines, such as IL-6, which may cause the disease rapidly developed into ARDS and prolonged disease course. 32 In this study, we found that in patients with severe COVID-19 pneumonia, CD3 + , CD4 + , CD8 + cell counts of the alveolar lavage fluid and serum in the survival group were significantly higher than those in the death group. In the survival group, the IL-6, HS-CRP, and PCT of the level alveolar lavage fluid and serum were lower than those in the death group, the difference was statistically significant (p < .05); suggesting that the T lymphocyte count and inflammatory factors are positively correlated with the severity of the disease. The study also found that the levels of CD3 + , CD4 + , CD8 + in alveolar lavage fluid of the death group were significantly lower than those in the serum, while the levels of IL-6, PCT, and HS-CRP, were higher than those in the serum, indicating that viral infection leads to abnormal oxygen and carbon dioxide exchange in the alveoli, as well as secondary inflammation-mediated immune response disorder, which results in rapid disease progression. The correlation analysis of this study found that the levels of CD3 + , CD4 + , and IL-6 were significantly negatively correlated with SOFA and APACHE II score, suggesting that with the multiple organ dysfunction, the decrease of CD3 + and CD4 + and the increase of IL-6 are related to the severity of COVID-19 pneumonia. To accurately assess the criticality of a patient's condition, ICU physicians usually need to collect a variety of clinical laboratory data to calculate SOFA scores, including oxygenation index, platelet count, bilirubin, blood pressure, Glasgow score, creatinine, and urine output, which is a relatively time-consuming process. By performing a binary logistic analysis in this study, the CD4 + cells and SOFA score were considered as independent risk factors affecting the prognosis of patients with severe COVID-19 pneumonia. Furthermore, the area under the curve of CD4 + was 77.7% through the ROC curve, suggesting that the level of CD4 + cell has a certain clinical value in determining the prognosis of patients with COVID-19 pneumonia and its diagnostic efficacy is not different from SOFA with the area of 77.5% under the curve. However, there are a few limitations of this study: first, this is a single-center study, so the sample size is not large enough and there may be biases in the results. Second, this study lacks the correlations between these inflammatory factors and lymphocytes in serum and tissues. In this case, autopsies would be useful. Finally, we were unable to further investigate the long-term prognosis of patients. The authors declare that there are no conflict of interests. Liang Liao performed the sample collections, medical care and attention, and statistics. Guohui Yang offered guidance for this study. The data that support the findings of this study are available from the corresponding author upon reasonable request. The ethics committee of the Ezhou Central Hospital approved the study. As the disease was highly contagious, written informed consent was abandoned. http://orcid.org/0000-0001-7304-7502 Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study COVID-19: what is next for public health? Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients The reproductive number of COVID-19 is higher compared to SARS coronavirus Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Severe acute respiratory syndrome: historical, epidemiologic, and clinical features Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan Clinical features of patients infected with 2019 novel coronavirus in Wuhan Diagnosis and treatment protocol for novel coronavirus pneumonia (trial version 7) SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 Consensus of Chinese experts on detection of related drive genes in target therapy of non-small cell lung cancer Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways Multiple organ infection and the pathogenesis of SARS Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis COVID-19 like findings in a fatal case of idiopathic desquamative interstitial pneumonia associated with IgA glomerulonephritis in a 13-month-old child Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues Oxidant stress and endothelial cell dysfunction Inflammation and endothelial dysfunction during aging: role of NF-kappaB Mitochondrial fusion is essential for organelle function and cardiac homeostasis Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria Cardiomyocyte death: mechanisms and translational implications Role of endothelial nitric oxide in pulmonary and systemic arteries during hypoxia Acute kidney injury in critically ill patients with lung disease: kidney-lung crosstalk. Rev Bras Ter Intensiva Genetic roadmap for kidney involvement of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis Is there a role for TNFalpha blockade in ANCA-associated vasculitis and glomerulonephritis? Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease SARS-CoV-2 and viral sepsis: observations and hypotheses Endothelial cell infection and endotheliitis in COVID-19 Pharmacological Agents Targeting Thromboinflammation in COVID-19: review and Implications for Future Research Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV A pneumonia outbreak associated with a new coronavirus of probable bat origin Acute respiratory distress revealing antisynthetase syndrome SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls Evaluation of clinical and immunological effects of inactivated influenza vaccine in children with asthma Anti-immunology: evasion of the host immune system by bacterial and viral pathogens NK-CD11c + cell crosstalk in diabetes enhances IL-6-mediated inflammation during Mycobacterium tuberculosis infection Levels of interleukin (IL)-6 and IL-8 are elevated in serum and bronchoalveolar lavage fluid of haematological patients with invasive pulmonary aspergillosis The role of interleukin-6 as an early predictor of sepsis in a murine sepsis model Clinical significance of cellular immunity function and inflammatory factors assays in alveolar lavage fluid for severe COVID-19 pneumonia